uk-dfsrh MCQ (SBA): Drospirenone POP Spironolactone Hyperkalaemia Risk

Instant feedback + full explanation. One question, done properly.

HardPrescribing & PharmacologyDrospirenone POP Spironolactone Hyperkalaemia Riskuk-dfsrh

A 26-year-old woman is started on the DRSP 4 mg POP and is also taking spironolactone for acne. What precaution is needed?

Educational content. Not a substitute for clinical judgement or local policy.

uk-dfsrh MCQ: Drospirenone POP Spironolactone Hyperkalaemia Risk — Ans